Entity Addresses, Address Type [Axis]
Business Contact [Member]
Types of share-based payment arrangements [axis]
Settlement related revenue [member]
Components of equity [axis]
Ordinary shares [member]
Share premium [member]
Capital reserve [member]
Retained earnings [member]
Classes of share capital [axis]
Eight ordinary shares [member]
One ordinary shares [member]
Range [axis]
Bottom of range [member]
Top of range [member]
Maturity [axis]
One year [member]
Two to three years [member]
More than three years [member]
Currency in which information is displayed [axis]
NIS [member]
US dollar [member]
Euro [member]
Other [member]
Classes of property, plant and equipment [axis]
Property [member]
Vehicles [member]
Property, plant and equipment by operating lease status [axis]
Office lease building [member]
Office furniture and equipment [member]
Computers and software [member]
Laboratory equipment and machines [member]
Categories of related parties [axis]
GE healthcare global holdings [member]
Second year agreement [member]
Attribution of expenses by nature to their function [axis]
LLI components [member]
Investment agreement [member]
Contigent forward contract [member]
Distribution agreement [member]
Counterparties [axis]
GEHC [member]
Israel innovation authority [member]
Koril [member]
General meeting [member]
Executive officer [member]
Employees [member]
Types of contracts [axis]
Employees option plan [member]
Types Of Payment Arrangements [Axis]
Stock Options [Member]
Geographical areas [axis]
ISRAEL
UNITED STATES
KOREA, REPUBLIC OF
Clalit health services [member]
Europe [Member]
Classes of financial instruments [axis]
Cost of revenues [member]
Research and development [member]
Sales and marketing [member]
General and administrative expenses [member]
Financial expenses [member]
Financial income [member]
Key management personnel of entity or parent [member]
Non-adjusting events after reporting period [axis]
Nonadjusting event [member]
Entity Addresses [Table]
Entity Addresses [Line Items]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Contact Personnel Name
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Auditor Firm ID
Auditor Location
Auditor Name
Statement of financial position [abstract]
Assets
CURRENT ASSETS
Cash and cash equivalents
Short-term bank deposits
Restricted deposits
Trade receivables
Other receivables
Inventory - current portion
Total current assets
NON-CURRENT ASSETS
Inventory - non-current portion
Right-of-use assets
Property and equipment, net
Total non-current assets
Total assets
Liabilities and equity
CURRENT LIABILITIES
Trade payables
Other payables and accruals
Contract liabilities
Share-based compensation liability
Current maturities of liability for royalties to the Israel Innovation Authority
Current maturities of lease liabilities
Total current liabilities
Total current liabilities
NON-CURRENT LIABILITIES
Contract liabilities
Share-based compensation liability, net of current maturities
Liability for royalties to the Israel Innovation Authority, net of current maturities
Lease liabilities, net of current maturities
Total non-current liabilities
Total non-current liabilities
Total liabilities
EQUITY
Ordinary shares
Share premium
Capital reserve
Accumulated deficit
Total equity
Total liabilities and equity
Profit or loss [abstract]
Revenues
Revenues from settlement agreement with GEHC (*)
Total revenues
Cost of revenues
Gross profit
Research and development expenses, net
Sales and marketing expenses
General and administrative expenses
Operating loss
Financial expenses
Financial income
Financial expenses (income), net
Loss before income tax
Provision (benefit) for income tax
Net loss and comprehensive loss
Loss per ordinary share - basic
Loss per ordinary share - diluted
Disclosure of terms and conditions of share-based payment arrangement [table]
IfrsStatementLineItems [Line Items]
Revenues
Cancellation shares
Statement of changes in equity [table]
Balance
Net loss and comprehensive loss for the year
Share-based compensation
Exercise of options
Expiration of options
Balance
Statement of cash flows [abstract]
Net cash used in operating activities
Cash Flows from Investing Activities
Purchase of property and equipment
Proceeds from short-term deposits
Interest received
Net cash provided by investing activities, net
Cash Flows from Financing Activities
Exercise of options
Payment to the Israel Innovation Authority
Receipt of grants from Israel Innovation Authority
Principal portion of lease payments
Interest portion of lease payments
Net cash provided by (used in) financing activities
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of the year
Exchange differences on cash and cash equivalents
Cash and cash equivalents at end of the year
Net loss
Adjustments for:
Depreciation and amortization
Share-based compensation
Financial expenses (income)
Exchange differences
Adjustments for profit loss
Changes in operating asset and liability items:
Decrease (increase) in trade receivables
Decrease (increase) in other receivables
Decrease (increase) in inventory
Decrease in trade payables
Increase (decrease) in other payables and accruals
Increase (decrease) in contract liabilities
Increase in liability of share-based compensation
Changes in operating asset and liability items, net
Supplemental information on non-cash transactions:
Changes in right-of-use asset and lease liabilities
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Type [Axis]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Trading Arrangements, by Individual [Table]
Trading Arrangement [Axis]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Notes and other explanatory information [abstract]
GENERAL INFORMATION
MATERIAL ACCOUNTING POLICIES
New Ifrs Accounting Standards Amendments To Standards And New Interpretations
NEW IFRS ACCOUNTING STANDARDS, AMENDMENTS TO STANDARDS AND NEW INTERPRETATIONS
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT
CASH AND CASH EQUIVALENTS
TRADE AND OTHER RECEIVABLES
INVENTORY
LEASES
PROPERTY AND EQUIPMENT
TRADE PAYABLES AND OTHER PAYABLES AND ACCRUALS
EMPLOYEE BENEFITS
COMMITMENTS AND CONTINGENT LIABILITIES
EQUITY
TAXES ON INCOME
REVENUE FROM CONTRACTS WITH CUSTOMERS
RESEARCH AND DEVELOPMENT EXPENSES, NET
Sales And Marketing Expenses
SALES AND MARKETING EXPENSES
GENERAL AND ADMINISTRATIVE EXPENSES
FINANCIAL EXPENSES (INCOME), NET
BASIC AND DILUTED NET LOSS PER SHARE
RELATED PARTIES TRANSACTIONS AND BALANCES
Disclosure of events after reporting period [text block]
SUBSEQUENT EVENTS
Compliance with IFRS Accounting Standards and disclosure requirements
Basis of presentation of the financial statements
Translation of balances and transactions in foreign currency
Consolidated financial statements
Critical accounting estimates and judgments
SCHEDULE OF FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT
SCHEDULE OF CHANGES IN THE FINANCIAL INSTRUMENTS
SCHEDULE OF CASH AND CASH EQUIVALENTS
SCHEDULE OF COMPOSITION OF OTHER RECEIVABLES
SCHEDULE OF INVENTORIES
SCHEDULE OF ASSETS DEPRECIATED DETAILS
SCHEDULE OF RIGHT OF USE ASSETS
SUMMARY OF LEASE LIABILITIES
SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIVES
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT
SCHEDULE OF OTHER PAYABLES AND ACCRUALS COMPOSITION
SCHEDULE OF CHANGES IN LIABILITY OF ROYALTIES
SCHEDULE OF SHARE CAPITAL IS COMPOSED OF ORDINARY SHARES
SCHEDULE OF CHANGES IN OPTION
SCHEDULE OF OPTION ACTIVITY
SCHEDULE OF COMPREHENSIVE INCOME LOSS REVENUE
SCHEDULE OF COST OF REVENUE
SCHEDULE OF COMPREHENSIVE INCOME LOSS RESEARCH AND DEVELOPMENT EXPENSES
SCHEDULE OF SALES AND MARKETING EXPENSES
SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES
SCHEDULE OF FINANCIAL EXPENSES INCOME
SCHEDULE OF LOSS PER SHARE
SCHEDULE OF BALANCE RELATED PARTIES
SCHEDULE OF TRANSACTIONS RELATED PARTIES
SCHEDULE OF KEY MANAGEMENT PERSONNEL
Reverse share splits, description
Par value per share
Disclosure of detailed information about borrowings [table]
Interest rate
Exchange rate
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]
Liability of royalties to IIA
Lease liabilities
Liabilities
Balance as of January 1
Recognition of derivative financial instrument
Losses (profits) recognized in comprehensive loss
Balance as of December 31
IfrsStatementTable [Table]
Cash on hand and in bank
Government institutions
Advances to suppliers
Tax advances
Prepaid expenses
Other receivables (see note 12a(1))
Other receivables
Net loss
Foreign exchange
Concentration of credit risks
Raw materials
Work-in-progress
Finished goods
Inventories
Disclosure of detailed information about property, plant and equipment [table]
Lease expiration
Raw material
Finished goods
Right of use assets, Cost, Balance
Right of use assets, Cost, Additions
Right of use assets, Cost, Balance
Right of use assets, Accumulated amortization, Balance
Right of use assets, Accumulated amortization, Additions
Right of use assets, Accumulated amortization, Balance
Right of use assets
Right of use assets, Cost, Other changes
Balance - Beginning of Period
Additions
Interest expense
Payments
Balance - Beginning of Period
Short-term lease liabilities
Long-term lease liabilities
Lease liabilities
Other changes
Estimated useful life
Balance as of January 1, 2025
Additions
Balance as of December 31, 2025
Balance as of January 1, 2025
Additions
Balance as of December 31, 2025
Net book value
Salaries and payroll-related institutions
Provision for bonus
Provision for vacation and recreation pay
Accrued expenses and other liabilities
Other payables and accruals composition
Monthly rent payment
Lease term
Restricted deposit
Defined contribution plans
Disclosure of transactions between related parties [table]
Royalty
Payments to the IIA
Proceeds from the IIA
Financial expenses
Royalty
Authorized share capital
Issued and paid-up share capital
Authorized share capital
Issued and paid-up share capital
Allocated number of share
Nominal value
Investment
Capital raised
Description of leasing arrangements
Cost
Interest payable
Description of cancel purchase order
Investment proceeds
Share issued
Derivative assets
Customer contract liability
Total Transaction Costs
Equity allocated
Comprehensive loss
Losses on change in fair value of derivatives
Contract term
Proceeds from related parties
Revenues
Financial value
Collaboration agreement term
Royalty due
Grant receive
Royalty expense
Royalty rate
TypesOfPaymentArrangementsAxis [Axis]
Outstanding Number of options
Weighted average exercise price, Beginning Balance
Number of options, Granted
Weighted average exercise price, Granted
Number of options, Expired
Weighted average exercise price, Expired
Number of options, Forfeited
Weighted average exercise price, Forfeited
Number of options, Exercised
Weighted average exercise price, Exercised
Number of options Outstanding, Ending Balance
Weighted average exercise price, Ending Balance
Number of Options Exercisable
Weighted average exercise price, Exercisable
Weighted average exercise price, Exercisable
Weighted average remaining contractual life in years
Description of vesting option
Number of option, grant
Number of option, Vested
Exercise price
Compensation expenses
Fair value
Expected volatility
Risk free interest rate
Expected life
Exercise price of share
Disclosure of disaggregation of revenue from contracts with customers [table]
Applicable tax rate
Loss carryforwards
Revenue
Other
Disclosure of detailed information about financial instruments [table]
Use of materials
Salaries and related expenses
Depreciation
Other
Raw materials and consumables
Consultants and subcontractors
Patents
Other
Salaries and related expenses
Net of grants from the IIA and KORIL
Contract liability
Revenue
Advertising
Office rent and maintenance
Sale and marketing
Professional services
Consulting services
Insurance
Bank fees
Change at fair value of financial instruments
Lease liabilities interest expenses
Financial expenses from liability for royalties to the IIA
Loss from exchange rate fluctuations
Financial income from liability for royalties to the IIA
Interest income from short-term deposits
Gain from exchange rate fluctuations
Financial income
Loss attributable to ordinary shares
Weighted average number of shares used in loss per share calculation
Basic loss per share
Outstanding options at end of the year issued as part of share-based compensation
Salaries and related benefits for related parties employed by the Company
Compensation for related parties not employed by the Company
Salaries and related benefits for related parties employed by the Company
Compensation for related parties not employed by the Company
Salaries and related expenses
Share-based compensation
Number of key management personnel
Other payables and accruals
Share-based compensation liability
Bonus
Monthly salary
Provision of bonus
Description of bonus
Disclosure of non-adjusting events after reporting period [table]
Name of acquiree
Total consideration for purchase
Disclosure of inventories information explanatory.
Restricted deposits.
Sharebased compensation liability.
Current maturities of liability.
Sharebased compensation liability non current.
Noncurrent maturities of liability.
Property [member]
Disclosure of detailed information about assets depreciated explanatory.
General meeting [member]
Rent payment.
Lease term.
Compensation expenses.
Executive officer [member]
Disclosure of detailed information about of right of use assets.
Current option fair value.
Expected life of options.
Employees [member]
Right of use assets accumulated amortization.
Right of use assets other changes.
Disclosure of change in warrants explanatory.
Revenues from settlement agreement with Gehc.
Types of payment arrangements [axis]
Stock options [member]
Exercise price of outstanding share options exercisable 2019.
Summary of detailed information about lease liabilities explanatory.
Additions on lease liabilities.
Increase decrease through expiration of options.
Other changes on lease liabilities.
Employees option plan [member]
Disclosure of detailed information aboute estimated useful life property and equipment explanatory.
Other [member]
Laboratory equipment and machines [member]
Property plant and equipment cost.
Accumulated depreciation property, plant and equipment.
Clalit health services [member]
Use of materials.
Other.
Payment to israel innovation authority.
Disclosure of information about expected research and development expense explanatory.
Interest portion of lease payments.
Changes in operating asset and liability.
Supplemental disclosure of noncash investing activities [Abstract]
Changes in right of use asset and lease liabilities.
Research and development [member]
Provision for vacation and recreation pay.
Provision for bonus.
Salaries and payroll related institutions.
Cost of revenues [member]
Disclosure of trader payables and accrued liabilities explanatory.
Raw materials and consumables.
Consultants and subcontractors.
Patents.
Increase decrease changes in operating asset and liability items net.
Grant received.
Description of reverse stock splits significant change in shares issued and outstanding.
GE healthcare global holdings [member]
One ordinary shares [member]
Eight ordinary shares [member]
Compliance with IFRS accounting standards and disclosure requirements explanatory.
Description of critical accounting estimates and judgments explanatory.
Disclosure of New Ifrs Accounting Standards Amendments To Standards And New Interpretations Explanatory.
One year [member]
Two to three years [member]
More than three years [member]
Liability of royalties.
Recognition of derivative financial instrument.
Office lease building [member]
NIS [member]
US dollar [member]
Euro [member]
Disclosure of detailed information of cash and cash equivalents explanatory.
Description of leasing arrangements.
Disclosure of basis of preparation of financial statement explanatory.
Second year agreement [member]
Contract liability.
LLI components [member]
Description of cancel purchase order.
Disclosure of sales and marketing expense explanatory.
Proceeds from issuance of equity instruments.
Investment agreement [member]
Disclosure of information about expected sales and marketing expense explanatory.
Contigent forward contract [member]
Distribution agreement [member]
Transaction costs deducted from equity.
Other operating expenses.
Office rent and maintenance.
Sales and marketing [member]
Contract term.
Disclosure composition of other receivables explanatory.
GEHC [member]
Disclosure of information about expected general and administrative expenses explanatory.
Consulting services.
Settlement related revenue [member]
General and administrative expenses [member]
Disclosure of information about expected financial expenses income explanatory.
Israel innovation authority [member]
Receive grant.
Tax advance.
Financial expenses [member]
Financial income [member]
Royalty rate.
Koril [member]
Disclosure of changes in liability of royalties explanatory.
Royalty.
Financial income expenses.
Disclosure of detailed information about balance with related parties explanatory.
Compensation related party transactions.
Disclosure of detailed information about transactions with related parties explanatory.
Bonus.
Monthly salary.
Nonadjusting event [member]
Description of bonus.
Raw materials current and non current.
Finished goods current and non current.
Provision bonus.
Transaction costs relating to issuance of equity instruments.
Office furniture and equipment [member]
Computers and software [member]
Research and development expense gross.
Authorized share capital.
Payments of lease liabilities.
Current non current lease liabilities.
Cancellation shares.
Revenue issued.
Government institutions.
Inventories current.
Net loss
custom:Proceeds from relating to royalties fees and commissions.
Proceeds from relatedparties
Collaboration agreement term
Disclosure of Detailed Information About Cost of Revenue Explanatory.
Number of outstanding share option.
Sharebased compensation liability current and noncurrent.
Current assets
Non-current assets
Assets [Default Label]
Non-current contract liabilities
Liabilities [Default Label]
Equity and liabilities
Gross profit
Operating expense excluding cost of sales
Finance income (expenses) from reinsurance contracts held recognised in profit or loss
Profit (loss) before tax
RevenueIssued
Cash flows from (used in) operating activities
Purchase of property, plant and equipment, classified as investing activities
Cash flows from (used in) investing activities
Proceeds from exercise of options
PaymentToIsraelInnovationAuthority
Payments of lease liabilities, classified as financing activities
InterestPortionOfLeasePayments
Cash flows from (used in) financing activities
NetLoss
Adjustments for share-based payments
Adjustments for finance income (cost)
Gains (losses) on exchange differences on translation of foreign operations, net of tax
Adjustments to reconcile profit (loss)
IncreaseDecreaseChangesInOperatingAssetAndLiabilityItemsNet
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Disclosure of share capital, reserves and other equity interest [text block]
Fair value of financial instrument on discontinuation of measurement at fair value through profit or loss because credit derivative is used to manage credit risk, assets
Current inventories
FinishedGoodsCurrentAndNonCurrent
Right-of-use assets, revalued assets, at cost
RightofuseAssetsAccumulatedAmortization
Lease liabilities [Default Label]
PaymentsOfLeaseLiabilities
PropertyPlantAndEquipmentCost
Additions other than through business combinations, property, plant and equipment
AccumulateddepreciationPropertyPlantAndEquipment
Property service charge income (expense)
Royalty
Payments relating to royalties, fees and commissions
FinancialIncomeExpenses
AuthorizedShareCapital
Issued capital
Number of share options outstanding in share-based payment arrangement
Weighted average exercise price of share options outstanding in share-based payment arrangement
Number of share options expired in share-based payment arrangement
Number of share options forfeited in share-based payment arrangement
Number of share options exercised in share-based payment arrangement
Number of share options exercisable in share-based payment arrangement
ExercisePriceOfOutstandingShareOptionsExercisable2019
Other [Default Label]
Miscellaneous other operating expense
ResearchAndDevelopmentExpenseGross
GrantReceived
Key management personnel compensation, short-term employee benefits
Key management personnel compensation, post-employment benefits
Key management personnel compensation, share-based payment
Key management personnel compensation, other long-term employee benefits
SharebasedCompensationLiabilityCurrentAndNoncurrent